SORA

Advancing, promoting and sharing knowledge of health through excellence in teaching, clinical practice and research into the prevention and treatment of illness

Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project.

Deloria Knoll, M; Bennett, JC; Garcia Quesada, M; Kagucia, EW; Peterson, ME; Feikin, DR; Cohen, AL; Hetrich, MK; Yang, Y; Sinkevitch, JN; et al. Deloria Knoll, M; Bennett, JC; Garcia Quesada, M; Kagucia, EW; Peterson, ME; Feikin, DR; Cohen, AL; Hetrich, MK; Yang, Y; Sinkevitch, JN; Ampofo, K; Aukes, L; Bacci, S; Bigogo, G; Brandileone, M-CC; Bruce, MG; Camilli, R; Castilla, J; Chan, G; Chanto Chacón, G; Ciruela, P; Cook, H; Corcoran, M; Dagan, R; Danis, K; de Miguel, S; De Wals, P; Desmet, S; Galloway, Y; Georgakopoulou, T; Hammitt, LL; Hilty, M; Ho, P-L; Jayasinghe, S; Kellner, JD; Kleynhans, J; Knol, MJ; Kozakova, J; Kristinsson, KG; Ladhani, SN; Lara, CS; León, ME; Lepp, T; Mackenzie, GA; Mad'arová, L; McGeer, A; Mungun, T; Mwenda, JM; Nuorti, JP; Nzoyikorera, N; Oishi, K; De Oliveira, LH; Paragi, M; Pilishvili, T; Puentes, R; Rafai, E; Saha, SK; Savrasova, L; Savulescu, C; Scott, JA; Scott, KJ; Serhan, F; Setchanova, LP; Sinkovec Zorko, N; Skoczyńska, A; Swarthout, TD; Valentiner-Branth, P; van der Linden, M; Vestrheim, DF; von Gottberg, A; Yildirim, I; Hayford, K; The Pserenade Team (2021) Global Landscape Review of Serotype-Specific Invasive Pneumococcal Disease Surveillance among Countries Using PCV10/13: The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) Project. Microorganisms, 9 (4). p. 742. ISSN 2076-2607 https://doi.org/10.3390/microorganisms9040742
SGUL Authors: Ladhani, Shamez Nizarali

[img] PDF Published Version
Available under License Creative Commons Attribution.

Download (1MB)
[img] PDF (Supplementary material) Supporting information
Download (354kB)

Abstract

Serotype-specific surveillance for invasive pneumococcal disease (IPD) is essential for assessing the impact of 10- and 13-valent pneumococcal conjugate vaccines (PCV10/13). The Pneumococcal Serotype Replacement and Distribution Estimation (PSERENADE) project aimed to evaluate the global evidence to estimate the impact of PCV10/13 by age, product, schedule, and syndrome. Here we systematically characterize and summarize the global landscape of routine serotype-specific IPD surveillance in PCV10/13-using countries and describe the subset that are included in PSERENADE. Of 138 countries using PCV10/13 as of 2018, we identified 109 with IPD surveillance systems, 76 of which met PSERENADE data collection eligibility criteria. PSERENADE received data from most (n = 63, 82.9%), yielding 240,639 post-PCV10/13 introduction IPD cases. Pediatric and adult surveillance was represented from all geographic regions but was limited from lower income and high-burden countries. In PSERENADE, 18 sites evaluated PCV10, 42 PCV13, and 17 both; 17 sites used a 3 + 0 schedule, 38 used 2 + 1, 13 used 3 + 1, and 9 used mixed schedules. With such a sizeable and generally representative dataset, PSERENADE will be able to conduct robust analyses to estimate PCV impact and inform policy at national and global levels regarding adult immunization, schedule, and product choice, including for higher valency PCVs on the horizon.

Item Type: Article
Additional Information: © 2021 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Keywords: global, invasive pneumococcal disease, pneumococcal conjugate vaccines, pneumococcal meningitis, surveillance
SGUL Research Institute / Research Centre: Academic Structure > Infection and Immunity Research Institute (INII)
Journal or Publication Title: Microorganisms
ISSN: 2076-2607
Language: eng
Media of Output: Electronic
Related URLs:
Publisher License: Creative Commons: Attribution 4.0
Projects:
Project IDFunderFunder ID
001World Health Organizationhttp://dx.doi.org/10.13039/100004423
UL1 TR001863NCATS NIH HHSUNSPECIFIED
INV-010429 / OPP1189065Bill and Melinda Gates Foundationhttp://dx.doi.org/10.13039/100000865
URI: https://openaccess.sgul.ac.uk/id/eprint/117512
Publisher's version: https://doi.org/10.3390/microorganisms9040742

Actions (login required)

Edit Item Edit Item